Trial
NCT00562185
Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian Cancer
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Texas Southwestern Medical Center
Collaborators
Ortho Biotech Clinical Affairs, L.L.C.
Condition
Ovarian Cancer
Intervention
carboplatin
Why stopped
Funding source withdrew funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-11-20